World's Best Scientists 2026 revealed!
Takehiko Yokomizo

Takehiko Yokomizo

D-Index & Metrics

Biology and Biochemistry

D-Index
59
Citations
16698
World Ranking
12344
National Ranking
847

Overview

Takehiko Yokomizo is affiliated with Juntendo University in Japan and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research work spans various subfields including physiology, molecular biology, immunology, epidemiology, and biochemistry.

The scientist has focused on topics such as asthma and respiratory diseases, liver disease diagnosis and treatment, lipid metabolism and biosynthesis, fatty acid research and health, dermatology and skin diseases, allergic rhinitis and sensitization, and diet and metabolism studies.

Some of Takehiko Yokomizo's recent papers include:

  • The UFM1 system regulates ER-phagy through the ufmylation of CYB5R3 (2022) published in Nature Communications
  • Eicosanoids in Skin Wound Healing (2020) published in International Journal of Molecular Sciences
  • n-3 Fatty Acid and Its Metabolite 18-HEPE Ameliorate Retinal Neuronal Cell Dysfunction by Enhancing Müller BDNF in Diabetic Retinopathy (2020) published in Diabetes
  • GWAS-identified bipolar disorder risk allele in the FADS1/2 gene region links mood episodes and unsaturated fatty acid metabolism in mutant mice (2023) published in Molecular Psychiatry
  • Ablation of fatty acid desaturase 2 (FADS2) exacerbates hepatic triacylglycerol and cholesterol accumulation in polyunsaturated fatty acid-depleted mice (2021) published in FEBS Letters

Frequent coauthors of Takehiko Yokomizo include:

  • Hyeon-Cheol Lee
  • Toshiaki Okuno
  • Kazuko Saeki
  • Takao Shimizu
  • Magnus Bäck

The scientist's work has regularly appeared in several publication venues, including:

  • IUPHAR/BPS Guide to Pharmacology CITE
  • PLoS ONE
  • The FASEB Journal
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cell Reports

Best Publications

  • Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

    Toshimasa Yamauchi;Junji Kamon;Yusuke Ito;Atsushi Tsuchida

  • A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis.

    Takehiko Yokomizo;Takashi Izumi;Kyungho Chang;Yoh Takuwa

  • A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders.

    Takehiko Yokomizo;Kazuhiko Kato;Kan Terawaki;Takashi Izumi

  • The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo

    Nan Chiang;Charles N. Serhan;Sven-Erik Dahlén;Jeffrey M. Drazen

  • Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.

    Hiroyuki Okamoto;Noriko Takuwa;Takehiko Yokomizo;Naotoshi Sugimoto

  • International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors

    Charles Brink;Sven-Erik Dahlén;Jeffrey Drazen;Jilly F. Evans

  • Leukotriene B4: metabolism and signal transduction.

    Takehiko Yokomizo;Takashi Izumi;Takao Shimizu

  • G2A Is a Proton-sensing G-protein-coupled Receptor Antagonized by Lysophosphatidylcholine

    Naoka Murakami;Takehiko Yokomizo;Toshiaki Okuno;Takao Shimizu

  • Hydroxyeicosanoids bind to and activate the low-affinity leukotriene B4 receptor, BLT2

    Takehiko Yokomizo;Kazuhiko Kato;Hiroshi Hagiya;Takashi Izumi

  • Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7.

    Magnus Bäck;Magnus Bäck;William S Powell;Sven-Erik Dahlén;Jeffrey M Drazen

  • Association of eNOS Glu298Asp Polymorphism With End-Stage Renal Disease

    Eisei Noiri;Hiroaki Satoh;Jun-ichi Taguchi;Sergey V. Brodsky

  • 12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2.

    Toshiaki Okuno;Yoshiko Iizuka;Hiroshi Okazaki;Takehiko Yokomizo

  • Critical Duration of Intracellular Ca2+ Response Required for Continuous Translocation and Activation of Cytosolic Phospholipase A2

    Tetsuya Hirabayashi;Kazuhiko Kume;Kenzo Hirose;Takehiko Yokomizo

  • Autophagy regulates lipid metabolism through selective turnover of NCoR1

    Tetsuya Saito;Akiko Kuma;Akiko Kuma;Yuki Sugiura;Yoshinobu Ichimura

  • Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses.

    Kan Terawaki;Takehiko Yokomizo;Takahide Nagase;Akiko Toda

  • The LTB4-BLT1 Axis Mediates Neutrophil Infiltration and Secondary Injury in Experimental Spinal Cord Injury

    Hirokazu Saiwai;Yasuyuki Ohkawa;Hisakata Yamada;Hiromi Kumamaru

  • The role of leukotrienes in allergic diseases

    Min Liu;Min Liu;Takehiko Yokomizo

  • ROCK-Isoform-Specific Polarization of Macrophages Associated with Age-Related Macular Degeneration

    Souska Zandi;Shintaro Nakao;Kwang Hoon Chun;Paolo Fiorina

  • International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions

    Magnus Bäck;Sven-Erik Dahlén;Jeffrey M. Drazen;Jilly F. Evans

  • Leukotriene receptors as potential therapeutic targets

    Takehiko Yokomizo;Motonao Nakamura;Takao Shimizu

Frequent Co-Authors

Takao Shimizu
Takao Shimizu University of Tokyo
Akira Matsuda
Akira Matsuda Juntendo University
Charles N. Serhan
Charles N. Serhan Brigham and Women's Hospital
Sven-Erik Dahlén
Sven-Erik Dahlén Karolinska Institute
Masutaka Furue
Masutaka Furue Kyushu University
Kenji Kabashima
Kenji Kabashima Kyoto University
Yukihiko Sugimoto
Yukihiko Sugimoto Kumamoto University
Satoshi Ishii
Satoshi Ishii Akita University
Jeffrey M. Drazen
Jeffrey M. Drazen Harvard University
Hiromasa Inoue
Hiromasa Inoue Kagoshima University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Takehiko Yokomizo

Trending Scientists